会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 91. 发明授权
    • Evoked response variability as an indicator of autonomic tone and surrogate for patient condition
    • 诱发反应变异性作为患者状况的自主神经和代谢指标
    • US06711439B1
    • 2004-03-23
    • US10077663
    • 2002-02-14
    • Kerry BradleyEuljoon ParkLaurence S. Sloman
    • Kerry BradleyEuljoon ParkLaurence S. Sloman
    • A61N1362
    • A61N1/371A61B5/4035
    • Modern implantable cardiac stimulation devices include processing and data storage capabilities that may be exploited to track myocardial condition and autonomic tone. Implantable devices have a capability to measure and store electrogram information over a period of time in a relatively large capacity memory, with advances in technology allowing increases in memory size. The evoked response varies in amplitude and morphology with changes in autonomic tone, ventricular filling, paced rate, and other parameters. The implantable cardiac device can be configured to sense and accurately quantify the evoked response, derive parameters from the quantified evoked response, store the parameters over long time periods, and derive variability statistics from the parameters to assist in tracking the patient's condition over time, and guiding the patient's therapy.
    • 现代可植入心脏刺激装置包括可被利用来追踪心肌状况和自主神经紧张的处理和数据存储能力。 可移植设备具有在相对大容量存储器中在一段时间内测量和存储电描记图信息的能力,技术的进步允许存储器大小增加。 诱发反应的幅度和形态随着自主神经调节,心室充盈,起搏率和其他参数的变化而变化。 可植入心脏装置可被配置为感测并准确量化诱发反应,从量化的诱发反应导出参数,在长时间段内存储参数,并从参数中导出可变性统计数据,以帮助随时间跟踪患者的状况,以及 指导患者的治疗。
    • 92. 发明授权
    • System and method for improving CRT response and identifying potential non-responders to CRT therapy
    • 用于改善CRT反应并鉴定CRT治疗的潜在无反应者的系统和方法
    • US08301246B2
    • 2012-10-30
    • US11759756
    • 2007-06-07
    • Euljoon ParkXiaoyi Min
    • Euljoon ParkXiaoyi Min
    • A61N1/368
    • A61N1/3686A61N1/36185A61N1/3627A61N1/3684
    • A method is disclosed that includes selecting an electrode configuration from a plurality of electrode configurations associated with electrodes of an implantable lead, sensing activity of the right ventricle and the left ventricle, determining an interval between sensed activity of the right ventricle and sensed activity of the left ventricle and determining whether the selected electrode configuration is suitable based at least in part on the interval. In one embodiment, an implantable device performs such a method to improve patient response to the CRT therapy, for example, by selecting a different electrode configuration if the current configuration is not suitable. Other exemplary methods, devices, systems, etc., are also disclosed.
    • 公开了一种方法,其包括从与可植入引线的电极相关联的多个电极配置中选择电极配置,感测右心室和左心室的活动,确定感测到的右心室的活动与感测的右心室的活动之间的间隔 并且至少部分地基于间隔来确定所选择的电极配置是否合适。 在一个实施例中,可植入装置执行这种方法以改善患者对CRT治疗的反应,例如,如果当前配置不合适,则通过选择不同的电极配置。 还公开了其它示例性方法,装置,系统等。
    • 93. 发明授权
    • Systems and methods for use with an implantable medical device for detecting stroke based on electrocardiac signals
    • 用于基于心电信号检测卒中的可植入医疗装置的系统和方法
    • US08241221B2
    • 2012-08-14
    • US12366526
    • 2009-02-05
    • Euljoon Park
    • Euljoon Park
    • A61B5/0205
    • A61B5/0472A61B5/0006A61B5/0031
    • Techniques are provided for detecting stroke within a patient using an implantable medical device in conjunction with an external confirmation system. In one example, a preliminary detection of stroke is performed by a subcutaneous monitor based on an analysis of features of an electrocardiogram (ECG) sensed within the patient. Exemplary ECG features indicative of possible stroke include the onset of prominent U-waves, the onset of notched T-waves, and changes in ST segment duration or QT duration or dynamic trends in these parameters. The monitor transmits a signal indicative of possible stroke to a bedside monitor or other external system, which generates a stroke questionnaire for use in confirming the stroke. Family members or other caregivers input answers to the questionnaire into the external system, which confirms or disconfirms the stroke. Emergency personnel can be automatically notified. Implantable systems that detect stroke based on intracardiac electrogram (IEGM) signals are also described herein.
    • 提供技术用于使用可植入医疗装置结合外部确认系统检测病人内的卒中。 在一个示例中,基于对在患者体内感测的心电图(ECG)的特征的分析,通过皮下监测器进行中风的初步检测。 指示可能的中风的示例性ECG特征包括突出U波的开始,开槽的T波,以及ST段持续时间或QT持续时间的变化或这些参数中的动态趋势。 监视器将指示可能的行程的信号发送到床边监视器或其他外部系统,其产生用于确认行程的笔画问卷。 家庭成员或其他护理人员将调查表的答案输入到外部系统中,这确认或不确定中风。 应急人员可以自动通知。 本文还描述了基于心内电描记图(IEGM)信号检测中风的植入式系统。
    • 96. 发明授权
    • Automatic system for determining bi-ventricular pacing responders
    • 用于确定双心室起搏应答者的自动系统
    • US07689280B1
    • 2010-03-30
    • US11290938
    • 2005-11-29
    • Mark W. KrollEuljoon Park
    • Mark W. KrollEuljoon Park
    • A61N1/08
    • A61N1/368A61N1/3627A61N1/36521A61N1/3684A61N1/37258
    • A method of predicting a patient's response to multi-chamber pacing by implanting at least three sensing electrodes, measuring across at least two different impedance vectors of the heart via the three electrodes to obtain at least two impedance signals, and evaluating the at least two impedance signals for indications of contractile dysynchrony. Contractile dysynchrony indicates that the patient is likely to have a positive response to multi-chamber pacing. Also an implantable cardiac stimulation device with an implantable housing, a stimulation pulse generator positioned within the housing, at least two implantable leads, and a controller communicating with the pulse generator to induce the generator to deliver therapeutic stimulation to a patient's heart. The leads are arranged to measure a physiological parameter along at least two different spatial orientations. The controller evaluates relative timing of the physiological parameters along the different orientations for indications of contractile synchrony of the patient's heart.
    • 一种通过植入至少三个感测电极来预测患者对多室起搏的反应的方法,通过三个电极测量心脏的至少两个不同阻抗向量,以获得至少两个阻抗信号,并评估至少两个阻抗 用于收缩异常现象的信号。 收缩异常表示患者可能对多室起搏有积极的反应。 还有一种具有可植入壳体的可植入心脏刺激装置,位于壳体内的刺激脉冲发生器,至少两个可植入引线,以及与脉冲发生器通信以使发生器向患者心脏输送治疗刺激的控制器。 引线布置成沿着至少两个不同的空间取向测量生理参数。 控制器评估沿着不同方向的生理参数的相对时间,用于指示患者心脏的收缩同步。
    • 97. 发明授权
    • Method and system to graphically display programming parameters for multi-chamber devices
    • 用于图形显示多室设备的编程参数的方法和系统
    • US07333856B1
    • 2008-02-19
    • US10847709
    • 2004-05-17
    • Siew Bee ErQiuju HuangEuljoon ParkPaul A. Levine
    • Siew Bee ErQiuju HuangEuljoon ParkPaul A. Levine
    • A61N1/362
    • A61N1/37247
    • A method and system for programming an implantable therapeutic stimulation device sensing from and delivering therapeutic stimulations to multiple sites within a patient under a plurality of programmable parameters. The method includes automatically determining which parameters need to be programmed, graphically indicating specific parameters that need to be programmed in a spatial correspondence to the affected sites in the patient and/or displaying a waveform corresponding to expected physiological activity with the programming, and providing control inputs to program the specific parameters. The method can also include automatically evaluating the programmed parameters, and if errors exist in the programming, indicating the errors and awaiting corrective input, else programming the implantable device. The method can also include automatically determining a number of sensing and stimulation electrodes connected to the device.
    • 一种用于编程可植入治疗刺激装置的方法和系统,其在多个可编程参数下感测并向患者内的多个部位递送治疗刺激。 该方法包括自动确定哪些参数需要被编程,以图形方式指示需要编程的具体参数与病人的受影响部位的空间对应,和/或显示与编程有关的预期生理活动的波形,以及提供控制 输入来编程具体参数。 该方法还可以包括自动评估编程参数,并且如果编程中存在错误,指示错误并等待校正输入,则编程可植入设​​备。 该方法还可以包括自动确定连接到该装置的感测和刺激电极的数量。
    • 100. 发明授权
    • System and method for monitoring cardiac function via cardiac sounds using an implantable cardiac stimulation device
    • 使用可植入心脏刺激装置通过心脏声音监测心脏功能的系统和方法
    • US07139609B1
    • 2006-11-21
    • US10346809
    • 2003-01-17
    • Xiaoyi MinPaul A. LevineEuljoon Park
    • Xiaoyi MinPaul A. LevineEuljoon Park
    • A61B5/02A61N1/365
    • A61N1/36585A61B5/02A61B5/04004A61B5/0402A61B5/7239A61B7/04A61N1/3627
    • Techniques are provided for performing internal measurement of heart sounds to estimate patient cardiac function in terms of stroke volume, cardiac output, or a maximum rate of change of aortic pressure with time (max dP/dt). Control parameters of the medical device are then automatically adjusted so as to optimize overall cardiac function or to provide for ventricular resynchronization therapy. In one example, heart sound signals are derived from acceleration signals received from an accelerometer. The heart sound signals are analyzed to identify S1 and S2 heart sounds as well as ejection period and isovolumic interval (ISOV). Proxies for max dP/dt, stroke volume and cardiac output are then derived from the S1 and S2 heart sounds, the ejection period and the ISOV. Alternative techniques, not requiring detection of ISOV, are employed for use if the patient has heart value regurgitation.
    • 提供技术用于进行心脏声音的内部测量,以根据中风量,心输出量或主动脉压随时间的最大变化率(最大dP / dt)来估计患者心脏功能。 然后自动调节医疗装置的控制参数,以便优化整体心脏功能或提供心室再同步治疗。 在一个示例中,从加速度计接收的加速度信号导出心音信号。 分析心音信号以识别S1和S2心音,以及射血期和等容间隔(ISOV)。 然后从S1和S2心脏声音,射血期和ISOV导出最大dP / dt,搏出量和心输出量的代理。 如果患者有心脏反流,则采用不需要检测ISOV的替代技术。